Related Experiment Video

Updated: Jun 14, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Enhancing reader confidence through dual-time imaging and alternative reconstruction algorithms with [18F]PSMA-1007

Emil Novruzov1,2, Gabriel Sheikh3, Anna Feisthauer4

  • 1Department of Nuclear Medicine, Medical Faculty, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf, Moorenstrasse 5, 40225, Duesseldorf, Germany. Emil.Novruzov@med.uni-duesseldorf.de.

EJNMMI Research
|March 3, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Biochemical recurrenceDelayed imagingPSMA-RADS frameworkProstate cancerTOF and PSF reconstruction algorithm[18F]PSMA-1007 imaging

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...